PG vs SGMT · P/E 25, rev $84.28B vs rev $2.0M
Procter & Gamble Company (PG) versus Sagimet Biosciences Inc. Series A Common Stock (SGMT) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
PG currently screens at market cap $373.53B and trailing P/E 25.3. SGMT currently screens at market cap $403.2M.
Not investment advice. Open the PG and SGMT stock pages for the full models.
Not investment advice.